Survival Impact of Increasing Time to Treatment Initiation for Patients With Head and Neck Cancer in the United States

Abstract

Purpose To estimate the overall survival (OS) impact from increasing time to treatment initiation (TTI) for patients with head and neck squamous cell carcinoma (HNSCC). Methods Using the National Cancer Data Base (NCDB), we examined patients who received curative therapy for the following sites: oral tongue, oropharynx, larynx, and hypopharynx. TTI was the number of days from diagnosis to initiation of curative treatment. The effect of TTI on OS was determined by using Cox regression models (MVA). Recursive partitioning analysis (RPA) identified TTI thresholds via conditional inference trees to estimate the greatest differences in OS on the basis of randomly selected training and validation sets, and repeated this 1,000 times to ensure robustness of TTI thresholds. Results A total of 51,655 patients were included. On MVA, TTI of 61 to 90 days versus less than 30 days (hazard ratio [HR], 1.13; 95% CI, 1.08 to 1.19) independently increased mortality risk. TTI of 67 days appeared as the optimal threshold on the training RPA, statistical significance was confirmed in the validation set (P ≤ .001), and the 67-day TTI was the optimal threshold in 54% of repeated simulations. Overall, 96% of simulations validated two optimal TTI thresholds, with ranges of 46 to 52 days and 62 to 67 days. The median OS for TTI of 46 to 52 days or fewer versus 53 to 67 days versus greater than 67 days was 71.9 months (95% CI, 70.3 to 73.5 months) versus 61 months (95% CI, 57 to 66.1 months) versus 46.6 months (95% CI, 42.8 to 50.7 months), respectively (P < .001). In the most recent year with available data (2011), 25% of patients had TTI of greater than 46 days. Conclusion TTI independently affects survival. One in four patients experienced treatment delay. TTI of greater than 46 to 52 days introduced an increased risk of death that was most consistently detrimental beyond 60 days. Prolonged TTI is currently affecting survival.

Diagnostic Pathway of Oral Cavity Cancer in an Integrated Health Care System

“…19 That national study of more than 50,000 patients with head and neck cancer found that a treatment delay of 2 weeks was associated with worse survival. 19 Although the study did not report information pertaining to the diagnostic intervals, one can infer that decreasing diagnostic delays may confer survival benefit as well. Includes cheek lesion (n = 10), floor-of-mouth lesion (n = 30), gum lesion (n = 26), and palate lesion (n = 10).…”

Disparities in radiation therapy delivery: current evidence and future directions in head and neck cancer

“…Prolonged time from cancer diagnosis to treatment initiation may have an impact on tumor control and mortality [4][5][6]. Murphy et al noted significant variation in time to treatment initiation by race, Hispanic ethnicity, insurance status, zip-code-level income, zip-code-level education, and age among patients with HNC in the NCDB [6].…”

Improved survival of head and neck cancer patients in Greenland

“…Early diagnosis of head and neck cancer is important as it has been shown that diagnostic delay increases risk of mortality [6]. Furthermore, it is known that head and neck cancer proliferate rapidly and that delay in treatment initiation can result in stage progression [7,8] and have a negative effect on survival [9]. This emphasises the importance of reducing diagnostic delay and treatment delay to ensure better prognosis for patients with head and neck cancer.…”